The challenge of cardiovascular diseases in HIV-positive patients: it's time for redrawing the maps of cardiovascular risk?

被引:7
|
作者
Ceccarelli, G. [1 ]
d'Ettorre, G. [1 ]
Vullo, V. [1 ]
机构
[1] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy
关键词
DIAGNOSTIC-CLINICAL MANAGEMENT; IMMUNE ACTIVATION; ANTIRETROVIRAL AGENTS; ITALIAN GUIDELINES;
D O I
10.1111/ijcp.12066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [31] Metabolic Syndrome Prevalence and Cardiovascular Risk Assessment in HIV-Positive Men with and without Antiretroviral Therapy
    Lu, Win-Long
    Lee, Yuan-Ti
    Sheu, Gwo-Tarng
    MEDICINA-LITHUANIA, 2021, 57 (06):
  • [32] Lipid profile and cardiovascular risk of hiv positive patients on antiretroviral therapy
    Novakovic, M.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 118 - 118
  • [33] CARDIOVASCULAR RISK FACTORS ASSOCIATED WITH LOWER BASELINE COGNITIVE PERFORMANCE IN HIV-POSITIVE PERSONS Reply
    Wright, E.
    Grund, B.
    Robertson, K.
    Brew, B.
    Price, R.
    NEUROLOGY, 2011, 77 (04) : 407 - 407
  • [34] Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat
    Wang, Ting
    Yi, Ru
    Green, Linden Ann
    Chelvanambi, Sarvesh
    Seimetz, Michael
    Clauss, Matthias
    CARDIOVASCULAR PATHOLOGY, 2015, 24 (05) : 279 - 282
  • [35] Screening and management of risk factors for cardiovascular disease in HIV-positive patients attending an Australian urban sexual health clinic
    Kakar, Sheena
    Drak, Douglas
    Amin, Tahiya
    Cheung, Jason
    O'Connor, Catherine
    Gracey, David
    SEXUAL HEALTH, 2017, 14 (02) : 198 - 200
  • [36] Integrated versus referred management of cardiovascular disease (CVD) risk factors for HIV-positive patients on antiretroviral therapy in Swaziland
    Bongomin, P.
    Rabkin, M.
    Palma, A. M.
    McNairy, M. L.
    Simelane, S.
    Gachuhi, A. B.
    Bitchong, R.
    Biribonwoha, H. N.
    Okello, V.
    El-Sadr, W. M.
    ANTIVIRAL THERAPY, 2018, 23 : A9 - A9
  • [37] Cardiovascular risk evaluation of HIV-positive patients in a case-control study: comparison of the D:A:D and Framingham equations
    Markowicz, Samuel
    Delforge, Marc
    Necsoi, Coca
    De Wit, Stephane
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 19 - 20
  • [38] Cardiovascular disease Framingham risk score (FRS) and VACS index are associated with neurocognitive impairment (NCI) in HIV-positive patients
    Pinnetti, C.
    Balestra, P.
    Libertone, R.
    Lorenzini, P.
    Ricottini, M.
    Plazzi, M.
    Menichetti, S.
    Tozzi, V.
    Antinori, A.
    Ammassari, A.
    ANTIVIRAL THERAPY, 2013, 18 : A76 - A76
  • [39] Cardiovascular risk factors in hypertensive patients with positive or negative family history of premature cardiovascular diseases - the RISK study population
    Kolasinska-Malkowska, Katarzyna
    Niklas, Arkadiusz
    Lopatka, Pawel
    Posadzy-Malaczynska, Anna
    Tykarski, Andrzej
    ARTERIAL HYPERTENSION, 2008, 12 (04): : 277 - 284
  • [40] Associations of Hepatosteatosis With Cardiovascular Disease in HIV-Positive and HIV-Negative Patients: The Liverpool HIV-Heart Project
    Heseltine, Thomas
    Murray, Scott
    Ortega-Martorell, Sandra
    Olier, Ivan
    Lip, Gregory Y. H.
    Khoo, Saye
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 87 (05) : 1221 - 1227